Rapid Result
Trimipramine Rapid Test (TML)
Rapid urine test for detection of Trimipramine (TML).
CE Certified
ISO 13485
Why Choose reOpenTest Toxicology & Drug Monitoring Kits?
Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.
Rapid Screening
Provides results quickly, facilitating immediate decision-making.
Simple to Use
Easy to perform with minimal training required.
Urine Sample
Utilizes a non-invasive urine sample.
Product Overview
Qualitative immunoassay designed for the rapid detection of trimipramine in human urine samples. Aids in diagnosis of trimipramine overdose or misuse in clinical settings. Results are visually interpreted.
Technical Specifications
| Detection Target | Trimipramine (TML) |
|---|---|
| Sample Type | Urine |
| Methodology | Immunochromatography |
| Detection Range | Positive/Negative |
| Reaction Time | 10 minutes |
| Storage Conditions | 2-30u00b0C |
| Shelf Life | 18 months |
Procedure & Interpretation
Step-by-Step Procedure
- Collect a urine sample.
- Apply the urine sample to the test device.
- Read the results at 10 minutes.
Result Interpretation
Positive:
Only the control line appears; the test line is absent.
Negative:
Both the control and test lines are visible.
Invalid:
The test is invalid if the control line is not visible.
Frequently Asked Questions
The test is designed for rapid detection of trimipramine in urine, useful for screening potential overdose or misuse.
No, the test provides qualitative results (positive/negative) and is not intended for quantitative analysis.
This test is suitable for use by healthcare professionals in clinical settings.
Technical Documents
Download product inserts and brochures for detailed information.
No technical documents are available at this time. Please check back soon.
Partner with reOpenTest
Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.